INTRODUCTION The CHA2DS2 -VASc and R2CHA2DS2-VASc scoring systems were designed to stratify thromboembolic risk in patients with atrial fibrillation. The R2CHA2DS2-VASc score, compared with the ...

Olesen JB, Lip GYH, Hansen ML, et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ 2011; ...

Atrial fibrillation (AF) is the most common cardiac arrhythmia, and its diagnosis and management are crucial tasks for emergency physicians. An important aspect of treating patients with AF is ...

NEW ORLEANS, LA—Dabigatran 150mg was superior to warfarin and dabigatran 110mg was noninferior to warfarin for preventing stroke in patients with atrial fibrillation (AF) regardless of CHA2DS2-VASc ...

Female sex has a strong relationship with stroke risk in patients with nonvalvular A-fib, a new analysis affirms, but the disparity between women and men varies according to the presence of other risk ...

Please provide your email address to receive an email when new articles are posted on . The strongest predictors of incident AF with a HR of 1.2 or greater were hypertension, older age, CAD, HF, ...

Although patients with A-fib and those with atrial flutter (AFL) are generally managed by clinicians in much the same way for stroke prevention, new data suggest that a common risk score used for both ...

Please provide your email address to receive an email when new articles are posted on . CHICAGO — New data presented at the American Heart Association Scientific Sessions suggest that in a real-world ...

Adding blood tests to an existing risk calculator can help doctors suss out which patients with atrial fibrillation would most benefit from blood thinners, according to findings published Aug. 6 in ...

AF lasting less than 48 hours. In all patients, vWF and hs-CRP levels as well as IMT were measured and compared with the calculated CHA2DS2-VASc score. Result s We found a significant difference in ...

A recent British study published in European Heart Journal has reignited discussions on the role of sex as a determinant in prescribing anticoagulants, particularly for patients under the age of 65.